Genomic sequencing to screen newborns raises more false alarms than routine blood tests

STAT |
August 2020
Press

In this study led by UCSF researchers, exome sequencing was found to produce more false positives and false negatives for inherited metabolic disorders than the standard blood testing conducted in newborns. G2P’s Dr. Robert Green, co-leader of the BabySeq Project, speaks to the possibility “that the most comprehensive screening for newborns will be some combination … Continued

The Project Baseline Health Study: A step towards a broader mission to map human health

Gambhir S, Arges K, Assimes T, Bajaj V, Balu S, Bashir M, Beskow L, Blanco R, Califf R, Campbell P, Carin L, Christian V, Cousins S, Das M, Dockery M, Douglas P, Dunham A, Eckstrand J, Fleischmann D, Ford E, Fraulo E, French J, Ginsburg G, Green R... Shipes S, Sledge G, Spielman S, Spitler R, Schaack T, Swamy G, Willemink M, and Wong C
npj Digital Medicine June 2020  

Geneticist says DNA testing should be part of everyday healthcare

CNBC |
May 2020
Press, Video

Dr. Robert Green is the director of the Preventive Genomics Clinic at Brigham and Women’s Hospital in Boston. He believes that DNA testing combined with proper counseling and medical follow-up would be a critical element of a healthcare system that can prevent illness.

Of Known Significance

Clinical Omics |
March 2020
Press

An exclusive Clinical OMICs conversation with the director of Genomes2People, Robert Green, M.D., MPH

All in for All of Us

Brigham Clinical and Research News |
March 2020
Press

Through national research efforts like the All of Us Research Program, Brigham investigators and their collaborators are making genomic research more meaningful, equitable and impactful for all patients at the Brigham and around the world.

Reset your DNA to slow the clock

Neo Life |
December 2019
Press

A new epigenetic test that tracks molecular aging claims to show you how to stay biologically young. However, Robert Green says “epigenetic marks in apparently healthy people can tell them meaningful things about their health status is an overreach.”

Apple is offering free genetic tests to all its Silicon Valley employees

CNBC |
December 2019
Press

“It’s really exciting that to see companies move to preserve health, rather than just treating patients when they’re ill,” said Dr. Robert Green, a medical geneticist at Harvard Medical School and a co-founder of a genetics company called Genome Medical.

23 and baby

Nature |
December 2019
Press

We now have the ability to screen for thousands of genetic diseases in newborns. That may not always be the healthy thing to do.

China’s genetics giant wants to tailor medicine to your DNA

Bloomberg |
November 2019
Press

BGI is racing toward a world where your DNA informs your medical decisions—and maybe some of your personal ones. Bloomberg asks Dr. Robert Green on his thoughts regarding the medical advances in genomics in China and how they compare to those in the US.

Is preventive genomics elitist?

Medium |
October 2019
G2P Blog

The ultimate aim of our Genomes2People Research Program is to contribute to the transformation of medicine from reactive to proactive, from treatment-oriented to preventive. We are trying to help build the evidence base that will justify societal decision to make these technologies and services accessible to anyone who wants them, regardless of means, education or … Continued

Brigham and Women’s Hospital opens preventive genomics clinic

Genome Web |
August 2019
Press

“Preventive genomics is not yet recommended as standard of care,” Robert Green, director of the Preventive Genomics Clinic, said in a statement. “But for over two decades, our NIH-funded, randomized trials in translational genomics have generated consistent evidence that there are more potential medical benefits and fewer risks than previously considered. It is time for … Continued

NHGRI Announces Six Inaugural Genomic Innovator Awards

National Human Genome Research Institute |
August 2019
Press

Dr. Jason Vassey was announced as one of six recipients for the Genomic Innovator supporting early career investigators researching genome biology, genomic medicine, technology development and societal implications of genomic advances.

FDA stepping up actions against PGx testing, forcing some labs to stop reporting drug information

Genome Web |
August 2019
Press

Researchers led by Robert Green at Brigham and Women’s Hospital looked at whether consumers getting direct-to-consumer genetic testing were using PGx tests to change treatment decisions. Although this study relied on self-reported data from participants, it suggests that less than 1 percent could have made unsupervised medication changes based on their genetic test results.

Partners Biobank surpasses 100,000 participants

Brigham Bulletin |
August 2019
Press

“I would have never known that I was at risk if i hadn’t donated to the Biobank,” said Kristine Trudeau who knowingly enrolled in the Partners HealthCare Biobank because she wanted to help advance medicine and potentially save lives. She did not expect that it would save her own.

Should you get a home genetic test?

Harvard health Publishing |
February 2019
Press

More and more people want to explore their own medical data, and a DTC genetic test is one way to begin to understand some aspects of your future health.

The genetic counselor with a $4,000 DNA test

Bloomberg |
July 2019
Press, Video

At a new clinic in Boston, genetic counselor Carrie Blout helps healthy patients get their DNA tested for predispositions to more than 2500 diseases. Bloomberg’s Aki Ito goes through the testing herself, trialing a controversial technology at the forefront of modern medicine.